The Promise of Artificial Intelligence in Reshaping Anticancer Drug Development
Cells · 16.10.2024 · 13 (20) · 1709
DOI: 10.3390/cells13201709 ↗Kurz gefasst
Editorial in der Zeitschrift Cells, online erschienen am 16.10.2024. Verfasst von Kostas A Papavassiliou und 3 weiteren Autor:innen. Beteiligte Einrichtung: First University Department of Respiratory Medicine, Medical School, 'Sotiria' Hospital, National and Kapodistrian University of Athens, 11527 Athens…. Hauptthemen laut MEDLINE: Artificial Intelligence, Antineoplastic Agents, Drug Development. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
While the concept of artificial intelligence (AI) has deep historical roots, its development as a formal scientific field was initiated in the 1950s by Newell and Simon, who invented a “thinking machine” called the Logic Theorist [...]
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- First University Department of Respiratory Medicine, Medical School, 'Sotiria' Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
- Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
ORCID-Profile: Kostas A Papavassiliou, Amalia A Sofianidi, Vassiliki A Gogou, Athanasios G Papavassiliou
Zitieren
APA
Papavassiliou, K. A., Sofianidi, A. A., Gogou, V. A., & Papavassiliou, A. G. (2024). The Promise of Artificial Intelligence in Reshaping Anticancer Drug Development. Cells, 13(20), 1709. https://doi.org/10.3390/cells13201709
Vancouver
Papavassiliou KA, Sofianidi AA, Gogou VA, Papavassiliou AG. The Promise of Artificial Intelligence in Reshaping Anticancer Drug Development. Cells. 2024;13(20):1709. doi:10.3390/cells13201709
BibTeX
@article{Papavassiliou2024,
author = {Papavassiliou, Kostas A and Sofianidi, Amalia A and Gogou, Vassiliki A and Papavassiliou, Athanasios G},
title = {The Promise of Artificial Intelligence in Reshaping Anticancer Drug Development},
journal = {Cells},
year = {2024},
volume = {13},
number = {20},
pages = {1709},
doi = {10.3390/cells13201709}
}
EUVIMED